Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
Background: People who will participate in research studies need to undergo proper screening, evaluation, and assessment (SEA). SEA helps keep those who participate in studies safe. It also helps ensure accurate study results. The National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) wants to screen
| Condition(s) | Substance Use Disorder, Alcohol Use Disorder |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Background: People who will participate in research studies need to undergo proper screening, evaluation, and assessment (SEA). SEA helps keep those who participate in studies safe. It also helps ensure accurate study results. The National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) wants to screen people with alcohol and/or substance use disorders (ASUD) as well as people without ASUD for ongoing studies at NIDA in Baltimore, MD Objective: To screen people with or without ASUD for ongoing studies at NIDA. The ultimate goals are to learn why some people (1) use drugs; (2) stop using drugs; (3) use drugs but do not get addicted; and (4) never use drugs snd to develop ASUD treatments. Eligibility: People aged 18 years and older. They may (1) currently use nicotine, alcoh |
| Who can participate | * INCLUSION CRITERIA: This protocol is seeking individuals with current or past SUDs and/or AUD, as well as those who have never had an SUD or AUD. These individuals also may or may not be in treatment for their AUD/SUDs. To be eligible to participate in this study, an individual must meet the following criteria: * Age 18-99 years old. * Proficient ability to read, write, and understand English. * Stated willingness to comply with all screening procedures and availability for the duration of the screening period * Ability of subject to understand and the willingness to sign a written informed consent document. EXCLUSION CRITERIA: Individuals who lack capacity to consent to research participation to this protocol as determined by the Evaluation to Sign Consent (ESC). |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | National Institute on Drug Abuse (NIDA) |
| Locations | Baltimore, Maryland, United States |
| Start date | 2024-09-04 |
| NCT ID | NCT06552741 |
| Official listing | https://clinicaltrials.gov/study/NCT06552741 |